The not-for-profit’s strategy focused on community relationship-building and equity-oriented funding has other area groups rethinking their own procedures and how they share power with those they serve.
Eli Lilly and Co. turned in a profitable second quarter, but the results were shy of Wall Street analyst predictions. The drugmaker, however, saw revenue growth that topped Wall Street expectations.
Eli Lilly and Co. passed up the chance to develop a vaccine and instead focused on making antibody treatments for patients who were already infected with the coronavirus. That turned out to be a financial whiff. Now all eyes will be on Lilly’s second-quarter earnings, which the company will release early Tuesday.
With COVID numbers on the rise and businesses taking steps to require masks or vaccinations, IBJ is collected tidbits here. Check back regularly for updates.
Eli Lilly and Co. confirmed to IBJ on Thursday its mask requirement is effective immediately and is based on recommendations earlier this week from the CDC. Many other large employers, however, are still in a wait-and-see mode on imposing new restrictions on employees.
Prominent businesses such as Eli Lilly and Co., Cummins Inc., Roche Diagnostics and Salesforce are among the Indiana companies that signed the letter urging passage of the Equality Act.
Even as some drugmakers, including Indianapolis-based Eli Lilly and Co., are pushing to get experimental drugs approved, federal regulators are still dealing with a huge blowback over the controversial way they reviewed a new Alzheimer’s drug by rival Biogen.
The Indianapolis-based drugmaker said the deal to buy Protomer Technologies could be worth up to $1 billion if the technology meets certain milestones. Lilly did not say how much it was paying up front in cash.
The role of the sticky substance in the brain has long divided researchers and is at the forefront again amid the FDA’s recent clearance of the first drug to treat the disease in almost two decades.
While businesses were laying off employees last year by the boatload because of the pandemic, an Indianapolis company that specializes in building wind and solar farms hired scores of people to tackle new projects nationwide.
Some large downtown employers say they expect most or all of their workforce to return to the office full time. Others say they’re adopting hybrid models that offer employees the option to work remotely at least part of the time.
In her complaint, the lobbyist had claimed a top executive made sexist comments about her, mocked her physical appearance and subjected her and other women to a hostile work environment.
Eli Lilly and Co. shares jumped more than 9% Thursday morning after it received “breakthrough therapy” designation for donanemab from the U.S. Food and Drug Administration, putting the drug on a path that could expedite its development.
Mathilde Merlet oversees one of Eli Lilly and Co.’s fastest-growing products, a medicine called Taltz that treats a variety of dermatology and rheumatology disorders.
Dr. Jerome Adams has strong ties to central Indiana, having served as Indiana state health commissioner from 2014 to 2017. After the close of the Trump administration, he returned to the Indianapolis area to practice medicine.
The United Kingdom-based aircraft engine manufacturer is expected to jettison about 270,000 square feet of office space on its 2.2-acre campus at 450 S. Meridian St. About 3,000 people worked in the company’s downtown offices prior to the pandemic.
